Missing/wrong data?
Log in to edit
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET.
scientific article published on 20 June 2012
Author/s
author: Matthias Scheffler, Bernd Neumaier
Work details
Publication date
June 20, 2012
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.